The vacuum blood collection devices market is projected to attain USD 2.6 billion in 2023. Throughout the forecast period, the vacuum blood collection devices industry is projected to assume a CAGR of 6.3% to attain USD 4.79 billion by 2033.
The vacuum blood collection devices industry is projected to expand owing to the following:
Attributes | Details |
---|---|
Vacuum Blood Collection Devices Market Size (2023) | USD 2.6 billion |
Vacuum Blood Collection Devices Market Size (2033) | USD 4.79 billion |
Vacuum Blood Collection Devices Market CAGR (2023 to 2033) | 6.3% |
With the rise in blood tests performed to diagnose chronic diseases such as diabetes, human immunodeficiency virus (HIV), anemia, and cardiovascular diseases, the adoption of vacuum blood collection devices is forecast to reach USD 4.79 billion by the end of 2033.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rising prevalence of cancer has encouraged people for early diagnosis tests. Patients are opting for non-invasive diagnostic tools with growing awareness regarding the benefits of non-invasive test procedures.
Liquid biopsy has emerged as a promising and versatile non-invasive cancer diagnostic tool. Liquid biopsy analysis consists of circulating tumor cells, circulating cell-free nucleic acids, or other diseased cells from organs. This technique is especially acquiring immense popularity among the geriatric population.
With a surge in stabilizing reagents and the easy availability of vacuum blood collection devices, non-invasive diagnostic procedures have become easily accessible. As vacuum blood collection devices allow post-collection preservation of circulating cell-free DNA (cfDNA), medical professionals are increasingly advising liquid biopsy for cancer patients.
The evolution of the vacuum blood collection tube market depends on the blood preservation requirements after sample collection, which increases the interest in performing non-invasive diagnostic procedures. Advancements such as these are expected to provide a promising opportunity for the vacuum blood collection devices market.
Key players are fixating on creating technologically advanced and innovative products by investing in research and development activities to gain a competitive advantage. Increasing investment in research by biotechnology companies is also expected to provide ample growth opportunities for the market players.
Improvement and streamlining of regulatory processes and growing funding for life science research in developing countries are expected to boost the product portfolio and development of vacuum blood collection devices.
As key players are focusing on collaborations and the acquisition of regional distributors and other manufacturers for global expansion, the market is expected to witness impressive growth opportunities over the coming years.
According to Future Market Insights (FMI), the demand for vacuum blood collection devices recorded a CAGR of around 4.2% between 2018 and 2022. Increasing health check-ups due to the rising prevalence of chronic diseases, ease in sample collection and processing, and new product launches are the chief drivers, boosting the sales of vacuum blood collection devices.
As blood is considered a gold standard for diagnosis of infectious diseases and various other medical conditions, sales of vacuum blood collection devices market, have been witnessing significant growth during the pandemic phase. Factors such as these are expected to positively influence the development of the global vacuum blood collection devices market.
Future Market Insights projects the market to register a healthy CAGR of 6.3% by the end of 2033.
In 2023, the United States is expected to materialize as one of the most lucrative markets, accounting for a market share of over 87.3 % across North America. The growing popularity of health checkups drives growth in the country due to the rise in lifestyle and chronic disorders.
With advancements in biotechnology and ease in sample collection and processing, growth exhibited by the vacuum blood collection devices market is expected to improve. The presence of numerous key players in the country is the other factor driving the growth of the market in this region.
Germany is projected to dominate the Europe vacuum blood collection devices market, holding over 18.9% of the market share in 2023. Advancements in the market size can be credited to factors like increasing medical applications, growing product launches, technological advancements in the biotechnological industry, and the growing prevalence of chronic diseases in the country.
Country | China |
---|---|
Forecast CAGR % (2023 to 2033) | 9.7% |
The vacuum blood collection devices market in China is poised to expand at 9.7% CAGR through 2033. Demand is anticipated to increase due to the increase in diagnosis and physical examinations.
Favorable government policies, new product launches, and a rise in government funding for life science research are projected to boost the market. Growing product penetration and health awareness are among the key factors driving market growth in China.
Country | India |
---|---|
Forecast CAGR % (2023 to 2033) | 8.2% |
The vacuum blood collection devices market in India is anticipated to capture a CAGR of 8.2% during the forecast period. With a market share of over 69.3% in 2023, India is expected to spearhead the growth of South Asia.
Key factors aiding growth are the rising prevalence of infectious and chronic diseases in the country, an outbreak of contagious diseases such as COVID-19, and a rising focus on improving overall healthcare infrastructure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Segment | Serum Separation Tubes |
---|---|
Forecast CAGR % (2023 to 2033) | 6.7% |
In terms of product, the serum separation tubes are projected to hold the maximum share of 24.1%, expanding at 6.7% CAGR during the forecast period. As these serum separator tubes (SST) provide rapid separation of serum from cellular constituents of blood, medical professionals are extensively using them for the diagnosis of contagious diseases.
A plethora of benefits, such as easy transportation, minimal need for aliquoting serum, and reduction of analytical errors, are making serum separation tubes highly sought-after in the vacuum blood collection devices market.
In terms of material, plastic/PET material is projected to account for 84.5% of the market share in 2023. Demand in this segment is expected to continue increasing due to PET material’s resistance to breakage and high steam sterilization tolerance. Also, it can sustain cold storage temperatures without mechanical fatigue and deformation, which makes it ideal for vacuum blood collection devices.
Segment | Routine Chemistry |
---|---|
Forecast CAGR % (2023 to 2033) | 7.1% |
In terms of application, routine chemistry is projected to account for 34.2% of the market share in 2023. Routine chemistry is used to evaluate the body's electrolyte balance and the status of several body organs and empower individuals to make informed decisions about health. Also, this application segment is expected to record a CAGR of 7.1% during the forecast period.
In terms of end user, diagnostic laboratories are projected to account for 46.6% of the market share in 2023. Demand in the segment is anticipated to continue swelling owing to a heightened incidence rate of multiple diseases such as diabetes, hepatitis B, cancer, heart diseases, and HIV AIDS, whose diagnosis requires various blood tests to confirm the severity of the disease.
New product releases and approvals have emerged as key growth approaches employed by leading players in the vacuum blood collection devices market. Followed by this, the acquisition was the second most common strategy adopted by the industry players. For instance:
Attributes | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | USD million/billion for value and Units for Volume |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and the Middle East & Africa |
Key Countries Covered | The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, and South Africa |
Key Segments Covered | Product, Material, Application, End User, and Region |
Key Companies Profiled | Becton, Dickinson, & Company; Greiner Bio-One GmbH; Guangzhou Improve Medical Instruments Co., Ltd; AB Medical, Inc.; SARSTEDT AG & Co. KG; Cardinal Health; Poly Medicure Ltd.; FL Medical; InterVac Technology; Chengdu Rich Science Industry Co., Ltd.,; Zhejiang Gongdong Medical Technology Co. Ltd.; Aptaca Spa.; Hindustan Syringes & Medical Devices; DJO Global Inc.; BTL; Spectro Analytic Irradia AB; Photomedex; others |
Report Coverage | Market Forecast, brand share analysis, competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is projected to reach USD 4.79 billion by 2033.
Serum separation tubes hold a significant share of 24.1% though 2033.
Key players focus on collaborations, acquisitions, and global expansion.
China and India are significant players, growing at CAGRs of 9.7% and 8.2%, respectively.
The market is projected to register a CAGR of 6.3% by 2033.
Explore Healthcare Insights
View Reports